UFlex posts Q1 FY26 PAT at Rs. 58 Cr
The company’s virgin PET chips plant in Egypt, commissioned in Q4 FY25, achieved 74.8 per cent capacity utilization in its first full quarter. In India, the Panipat facility operated at 96.6 per cent utilization
The company’s virgin PET chips plant in Egypt, commissioned in Q4 FY25, achieved 74.8 per cent capacity utilization in its first full quarter. In India, the Panipat facility operated at 96.6 per cent utilization
Medical plastics make up about 25 per cent of the 14,000 tons of waste generated daily in US healthcare facilities
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
Plant-based chemistries have an outsized role to play for the HPC sector by meeting demand for good, gentle, and green products
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
Star Health Insurance is modernising its claims ecosystem to be future-ready
Changhua site meets international regulatory standards for global medical applications
The Swiss peptide and oligonucleotide manufacturers roll out major investments across site networks in US, UK and Switzerland
UFlex is the first and only Indian company to receive USFDA approval for its technology and capacity to recycle all three materials
Honeywell Aclar film technology will enable Evertis to develop high-quality barrier packaging solutions
Subscribe To Our Newsletter & Stay Updated